News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,948 Results
Type
Article (13752)
Company Profile (101)
Press Release (251095)
Section
Business (88034)
Career Advice (465)
Deals (15342)
Drug Delivery (67)
Drug Development (36596)
Employer Resources (49)
FDA (6287)
Job Trends (6196)
News (150195)
Policy (14025)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Adcomms (6)
Allergies (30)
Alliances (23211)
ALS (36)
Alzheimer's disease (383)
Antibody-drug conjugate (ADC) (35)
Approvals (6320)
Artificial intelligence (100)
Autoimmune disease (7)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (54)
Biotechnology (40)
Bladder cancer (18)
Brain cancer (15)
Breast cancer (74)
Cancer (568)
Cardiovascular disease (66)
Career advice (407)
Career pathing (11)
CAR-T (20)
Cell therapy (81)
Cervical cancer (4)
Clinical research (30839)
Collaboration (316)
Compensation (131)
Complete response letters (16)
COVID-19 (757)
CRISPR (19)
C-suite (112)
Cystic fibrosis (35)
Data (571)
Denatured (15)
Depression (9)
Diabetes (75)
Diagnostics (1314)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (54)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (33)
Earnings (32020)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37360)
Executive appointments (346)
FDA (6665)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (201)
Gene editing (37)
Generative AI (8)
Gene therapy (97)
GLP-1 (335)
Government (1285)
Grass and pollen (2)
Guidances (15)
Healthcare (3562)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (32)
Indications (12)
Infectious disease (788)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (43)
Interviews (59)
IPO (5874)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (10)
Layoffs (177)
Leadership (3)
Legal (3429)
Liver cancer (19)
Lung cancer (75)
Lymphoma (50)
Machine learning (1)
Management (16)
Manufacturing (139)
MASH (30)
Medical device (1272)
Medtech (1274)
Mergers & acquisitions (9651)
Metabolic disorders (241)
Multiple sclerosis (17)
NASH (14)
Neurodegenerative disease (21)
Neuropsychiatric disorders (6)
Neuroscience (543)
NextGen: Class of 2025 (1585)
Non-profit (593)
Northern California (659)
Now hiring (7)
Obesity (138)
Opinion (118)
Ovarian cancer (20)
Pain (49)
Pancreatic cancer (13)
Parkinson's disease (41)
Partnered (5)
Patents (101)
Patient recruitment (28)
Peanut (9)
People (28843)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8026)
Phase II (13048)
Phase III (11707)
Pipeline (364)
Podcasts (46)
Policy (58)
Postmarket research (1401)
Preclinical (3206)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (119)
Rare diseases (156)
Real estate (2633)
Recruiting (17)
Regulatory (10065)
Reports (14)
Research institute (563)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (32)
Series A (35)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (671)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1627)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6692)
Vaccines (149)
Venture capitalists (13)
Webinars (10)
Weight loss (93)
Women's health (8)
Worklife (3)
Date
Today (39)
Last 7 days (157)
Last 30 days (977)
Last 365 days (12079)
2025 (2808)
2024 (12501)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (52)
Arkansas (3)
Asia (20069)
Australia (2602)
California (1595)
Canada (862)
China (221)
Colorado (64)
Connecticut (65)
Delaware (51)
Europe (39319)
Florida (296)
Georgia (34)
Idaho (9)
Illinois (179)
India (13)
Indiana (126)
Iowa (1)
Japan (80)
Kansas (55)
Kentucky (12)
Maine (2)
Maryland (244)
Massachusetts (1373)
Michigan (27)
Minnesota (88)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (697)
New Mexico (7)
New York (465)
North Carolina (374)
North Dakota (2)
Northern California (659)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (404)
Puerto Rico (8)
Rhode Island (6)
South America (501)
South Carolina (2)
Southern California (671)
Tennessee (34)
Texas (213)
Utah (33)
Virginia (69)
Washington D.C. (29)
Washington State (109)
Wisconsin (14)
264,948 Results for "phathom pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 6, 2025
·
17 min read
Press Releases
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
January 30, 2025
·
1 min read
Press Releases
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025
February 24, 2025
·
1 min read
FDA
Phathom Scores Non-Erosive GERD Approval for Heartburn Drug
Already approved for erosive gastroesophageal reflux disease, Phathom’s Voquenza is now authorized to treat patients with non-erosive GERD.
July 18, 2024
·
1 min read
·
Kate Goodwin
Pharm Country
Phathom Pharmaceuticals to Participate in Upcoming June 2024 Investor Conferences
Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced that members of its management team are scheduled to participate in the following investor conferences in June.
May 28, 2024
·
1 min read
Press Releases
Phathom Pharmaceuticals to Participate in Upcoming November 2024 Investor Conferences
November 5, 2024
·
2 min read
Business
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, reported financial results for the first quarter of 2024, and provided recent business highlights.
May 9, 2024
·
13 min read
Pharm Country
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
Phathom Pharmaceuticals, Inc. today announced that the company will present data from multiple studies for its first-in-class treatment VOQUEZNA® (vonoprazan) including an oral presentation at Digestive Disease Week® (DDW) 2024, being held May 18-21 in Washington, D.C.
May 15, 2024
·
14 min read
Press Releases
Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 7, 2024
·
14 min read
Pharm Country
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Phathom Pharmaceuticals, Inc. announced today that members of the management team will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 9:30 a.m. ET.
April 3, 2024
·
1 min read
1 of 26,495
Next
